Form 4: Compass Pathways Director Malievskaia and Spouse Execute Stock Sales Under 10b5-1 Plans
SEC Form 4
Ekaterina Malievskaia, a director at Compass Pathways, and her spouse, George Jay Goldsmith, executed sales of ordinary shares under pre-arranged Rule 10b5-1 trading plans.
Summary
- Ekaterina Malievskaia, a director at Compass Pathways PLC, and her spouse, George Jay Goldsmith, executed sales of Compass Pathways ordinary shares.
- The sales were conducted under pre-arranged Rule 10b5-1 trading plans adopted on August 23, 2023.
- On May 2, 2024, Malievskaia sold 9,622 shares at a weighted average price of $8.2902, with prices ranging from $8.23 to $8.46.
- On May 2, 2024, Goldsmith sold 9,621 shares at a weighted average price of $8.2902, with prices ranging from $8.23 to $8.46.
- On May 3, 2024, Malievskaia sold 18,761 shares at a weighted average price of $8.8187, with prices ranging from $8.46 to $9.32.
- On May 3, 2024, Goldsmith sold 18,762 shares at a weighted average price of $8.8187, with prices ranging from $8.46 to $9.32.
- Following these transactions, Malievskaia directly owns 3,945,017 shares and indirectly owns 3,947,290 shares through her spouse.
- Malievskaia disclaims beneficial ownership of her spouse's shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating routine stock sales under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
Sales by insiders are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without being accused of acting on non-public information. The market will often scrutinize the timing and volume of such sales to gauge insider sentiment.
Stakeholder Impact
- Shareholders may interpret insider sales as a lack of confidence in the company's future prospects, although sales under 10b5-1 plans are often pre-scheduled and may not reflect current sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/23/2023 | Date of adoption of Rule 10b5-1 trading plans by Dr. Malievskaia and Mr. Goldsmith |
| 05/02/2024 | Date of stock sales by Dr. Malievskaia and Mr. Goldsmith |
| 05/03/2024 | Date of additional stock sales by Dr. Malievskaia and Mr. Goldsmith |
| 05/06/2024 | Date of signature of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.